JP6653116B2 - オルメサルタンのプロドラッグ製剤 - Google Patents

オルメサルタンのプロドラッグ製剤 Download PDF

Info

Publication number
JP6653116B2
JP6653116B2 JP2014172328A JP2014172328A JP6653116B2 JP 6653116 B2 JP6653116 B2 JP 6653116B2 JP 2014172328 A JP2014172328 A JP 2014172328A JP 2014172328 A JP2014172328 A JP 2014172328A JP 6653116 B2 JP6653116 B2 JP 6653116B2
Authority
JP
Japan
Prior art keywords
tablet
olmesartan medoxomil
stearic acid
olmesartan
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014172328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016044170A (ja
JP2016044170A5 (enExample
Inventor
一 山崎
一 山崎
健太 藤沼
健太 藤沼
桂子 毒島
桂子 毒島
英治 熊谷
英治 熊谷
康正 田代
康正 田代
剛 柳本
剛 柳本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Priority to JP2014172328A priority Critical patent/JP6653116B2/ja
Publication of JP2016044170A publication Critical patent/JP2016044170A/ja
Publication of JP2016044170A5 publication Critical patent/JP2016044170A5/ja
Application granted granted Critical
Publication of JP6653116B2 publication Critical patent/JP6653116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2014172328A 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤 Active JP6653116B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019089234A Division JP6765473B2 (ja) 2019-05-09 2019-05-09 オルメサルタンのプロドラッグ製剤

Publications (3)

Publication Number Publication Date
JP2016044170A JP2016044170A (ja) 2016-04-04
JP2016044170A5 JP2016044170A5 (enExample) 2017-08-24
JP6653116B2 true JP6653116B2 (ja) 2020-02-26

Family

ID=55635052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014172328A Active JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Country Status (1)

Country Link
JP (1) JP6653116B2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6602778B2 (ja) 2014-02-13 2019-11-06 インサイト・コーポレイション Ｌｓｄ１阻害剤としてのシクロプロピルアミン類
ES2750956T3 (es) 2014-02-13 2020-03-30 Incyte Corp Ciclopropilaminas como inhibidores de LSD1
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
EA201792205A1 (ru) 2015-04-03 2018-02-28 Инсайт Корпорейшн Гетероциклические соединения как ингибиторы lsd1
BR112018002553A8 (pt) 2015-08-12 2023-01-24 Incyte Corp Sais de um inibidor de lsd1
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
JP6765473B2 (ja) * 2019-05-09 2020-10-07 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤
WO2021145373A1 (ja) * 2020-01-16 2021-07-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 レンボレキサントの原薬及びそれを含有する医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5000491B2 (ja) * 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
US20070105923A1 (en) * 2005-09-14 2007-05-10 Glenmark Pharmaceuticals Limited Substantially pure olmesartan medoxomil and processes for its preparation
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
JPWO2008117707A1 (ja) * 2007-03-23 2010-07-15 第一三共株式会社 オルメサルタンメドキソミルの粉砕結晶
WO2010018777A1 (ja) * 2008-08-11 2010-02-18 第一三共株式会社 におい抑制方法
EA201170913A1 (ru) * 2008-12-30 2012-01-30 Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты Фармацевтические составы олмесартана
HUP0900384A2 (en) * 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate olmesartan medoxomil compositions
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition

Also Published As

Publication number Publication date
JP2016044170A (ja) 2016-04-04

Similar Documents

Publication Publication Date Title
JP6653116B2 (ja) オルメサルタンのプロドラッグ製剤
US20090281136A1 (en) Prasugrel pharmaceutical formulations
TW201717937A (zh) 含有芳基烷基胺化合物之醫藥組合物
AU2013365715B2 (en) A pharmaceutical composition containing candesartan cilexetil and amlodipine
JP2019031576A (ja) 非晶質体ソリフェナシン及び抗酸化剤を含有する固形製剤
WO2019004452A1 (ja) 医薬組成物
US20130146496A1 (en) Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
WO2014065390A1 (ja) メントールウィスカーの析出を抑制する方法
EA028329B1 (ru) Содержащая прасугрель стабильная фармацевтическая лекарственная форма с немедленным высвобождением для перорального введения, способ получения и применения
WO2020090969A1 (ja) 抗腫瘍剤を含む医薬組成物の包装体
JP6320260B2 (ja) 医薬組成物
JP6765473B2 (ja) オルメサルタンのプロドラッグ製剤
TWI689306B (zh) 經安定化而成之醫藥組成物
KR20150115334A (ko) 실로도신을 포함하는 과립물, 및 이를 포함하는 약학적 조성물 및 제형
EA015682B1 (ru) Фармацевтическая композиция
PT2919815T (pt) Uma composição farmacêutica contendo um inibidor eca e um bloqueador de canais de cálcio
WO2005099698A1 (ja) 安定化された４－アミノ－５－クロロ－Ｎ－［（１Ｒ，３ｒ，５Ｓ）－８－メチル－８－アザビシクロ［３．２．１］オクタ－３－イル]－２－［１－メチルブタ－２－インイルオキシ］ベンズアミド含有組成物
JP2017095441A (ja) アジルサルタン含有医薬組成物、医薬組成物におけるアジルサルタンの安定化方法、及びアジルサルタンの安定化剤
JP2021098671A (ja) レベチラセタム含有医薬組成物
JP6018420B2 (ja) アンジオテンシンｉｉ受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物
JP6750785B2 (ja) 安定なロスバスタチンカルシウム錠剤
JP6573098B2 (ja) 安定なロスバスタチンカルシウム錠剤
JP2021116283A (ja) エゼチミブおよびアトルバスタチン含有錠剤
WO2014188729A1 (ja) 経口用組成物
CN103446072A (zh) 帕洛诺司琼的固体药物组合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140828

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170712

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190701

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200127

R150 Certificate of patent or registration of utility model

Ref document number: 6653116

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250